Rheumatoid Arthritis

News Rheumatoid Arthritis

• IMS Health Lowers 2009 Global Pharmaceutical Market Forecast to 2.5 – 3.5 Percent Growth

  IMS Health reported that the value of the global pharmaceutical market is expected to grow 2.5 - 3.5 percent on a constant-dollar basis in 2009, two percentage points lower than indicated last October, as deterioration in the global economic environment continues to affect market demand. The update more

• IMS HEALTH Forecasts 4.5 - 5.5 Percent Growth for Global Pharmaceutical Market in 2009, Exceeding $820 Billion

  The global pharmaceutical market is expected to grow 4.5 - 5.5 percent next year, a pace similar to 2008, according to the IMS Global Pharmaceutical and Therapy Forecast™ released by IMS Health. The forecast predicts global pharmaceutical sales to surpass $820 billion in 2009, reflecting sustained d more

• Pfizer Says Research and Development Head John LaMattina Will Retire This Year

  Pfizer said that the President of Pfizer Global Research and Development, Dr. John LaMattina, who made many important contributions to the Company's research division throughout his 30-year career, will retire from Pfizer by the end of this year. The company will begin a search both inside and outsi more

Publications Rheumatoid Arthritis

• Azastilbenes: A cut off to p38 MAPK inhibitors

  Inhibitors with vicinal 4-fluorophenyl / 4-pyridine rings on a five- or six-membered heterocyclic ring are known to inhibit the p38 mitogen-activated protein kinase (MAPK), which is a potential target in for rheumatoid arthritis and several different types of cancer. Several substituted azastilbene- more

• Citrullinated Peptides in the Diagnosis of Rheumatoid Arthritis

  Abstract: Antibodies directed against citrullinated proteins and peptides (ACPAs) are the most specific serological markers available for diagnosing rheumatoid arthritis (RA). ACPAs may be detected several years before symptoms of RA appear, and their presence at disease onset is a good predi more

• Rheumatoid Arthritis: A Clinical Overview of New Diagnostic and Treatment Approaches

  Abstract: Rheumatoid arthritis (RA) is the most frequent form of chronic polyarthritis, affecting 0.5-1% of adults worldwide. In recent years there have been important advances in the pathogenesis of RA, together with new diagnostic and therapeutic insights. Early diagnosis is essential in or more

Websites Rheumatoid Arthritis